Unjha Formulations Ltd

NSE: UNJHAFOR · BSE: 531762 · Pharmaceuticals & Biotechnology · 4 announcements

Share price: ₹32.02
Market cap: ₹14.35 Cr
Revenue (annual): ₹15.59 Cr
Net profit (annual): ₹0.70 Cr
P/E (TTM): 30.4×Sector 50.4×
Promoter holding: 36.92%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 3

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

8 Sep 2026 15:38 IST BSE

Financial Results

Unjha Formulations Financial Results

Unjha Formulations filed the XBRL/XML financial statements for year ended 31/03/2026 with BSE. The submission includes Balance Sheet, P&L, and Cash Flow under SEBI LODR.

Read the filing ↗

5 Aug 2026 14:29 IST BSE

Financial Results

Unjha Formulations Q1 FY27 Results: Net Profit ₹0.2 Cr, Down 50.0% YoY

Unjha Formulations Ltd reported revenue from operations of ₹3.3 Cr (-8.3% YoY) and net profit of ₹0.2 Cr (-50.0% YoY) for Q1 FY27.

Key figure: Net profit ₹0.2 Cr · -50.0% YoY

Open full results → Read the filing ↗

3 Aug 2026 15:05 IST BSE

Financial Results

Unjha Formulations Q1 FY27 Results: Net Profit ₹0.2 Cr, Down 50.0% YoY

Unjha Formulations Ltd reported revenue from operations of ₹3.3 Cr (-8.3% YoY) and net profit of ₹0.2 Cr (-50.0% YoY) for Q1 FY27.

Key figure: Net profit ₹0.2 Cr · -50.0% YoY

Open full results → Read the filing ↗